BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Seo DH, Whang DH, Song EY, Han KS. Occult hepatitis B virus infection and blood transfusion. World J Hepatol 2015; 7(3): 600-606 [PMID: 25848484 DOI: 10.4254/wjh.v7.i3.600] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Esposito A, Sabia C, Iannone C, Nicoletti GF, Sommese L, Napoli C. Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc Testing. Transfus Med Hemother 2017;44:263-72. [PMID: 28924431 DOI: 10.1159/000460301] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
2 Safic Stanic H, Babic I, Maslovic M, Dogic V, Bingulac-Popovic J, Miletic M, Jurakovic-Loncar N, Vuk T, Strauss-Patko M, Jukic I. Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia. Transfus Med Hemother 2017;44:415-20. [PMID: 29344018 DOI: 10.1159/000457965] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
3 Ayana DA, Mulu A, Mihret A, Seyoum B, Aseffa A, Howe R. Occult Hepatitis B virus infection among HIV negative and positive isolated anti-HBc individuals in eastern Ethiopia. Sci Rep 2020;10:22182. [PMID: 33335238 DOI: 10.1038/s41598-020-79392-x] [Reference Citation Analysis]
4 Lunn RM, Jahnke GD, Rabkin CS. Tumour virus epidemiology. Philos Trans R Soc Lond B Biol Sci 2017;372:20160266. [PMID: 28893933 DOI: 10.1098/rstb.2016.0266] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
5 Sosa-Jurado F, Hilda Rosas-Murrieta N, Guzman-Flores B, Perez Zempoaltecalt C, Patricia Sanchez Torres A, Ramirez Rosete L, Bernal-Soto M, Marquez-Dominguez L, Melendez-Mena D, Angel Mendoza Torres M, Teresa Lopez Delgado M, Reyes-Leyva J, Vallejo-Ruiz V, Santos-Lopez G. Prevalence of Serologic Hepatitis B Markers in Blood Donors From Puebla, Mexico: The Association of Relatively High Levels of Anti-Core Antibodies With the Detection of Surface Antigen and Genomic DNA. Hepat Mon 2016;16:e36942. [PMID: 27630726 DOI: 10.5812/hepatmon.36942] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Lee KH, Shim KS, Lim IS, Chae SA, Yun SW, Lee NM, Choi YB, Yi DY. Changes in hepatitis B virus antibody titers over time among children: a single center study from 2012 to 2015 in an urban of South Korea. BMC Pediatr 2017;17:164. [PMID: 28705230 DOI: 10.1186/s12887-017-0924-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Wong GL, Wong VW, Chan HL. Virus and Host Testing to Manage Chronic Hepatitis B. Clin Infect Dis 2016;62 Suppl 4:S298-305. [PMID: 27190319 DOI: 10.1093/cid/ciw024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
8 Gao E, Hercun J, Heller T, Vilarinho S. Undiagnosed liver diseases. Transl Gastroenterol Hepatol 2021;6:28. [PMID: 33824932 DOI: 10.21037/tgh.2020.04.04] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Mikkelsen C, Mori G, van Walraven SM, Castrén J, Zahra S, MacLennan S, Seidel K, Fontana S, Veropalumbo E, Cannata L, Pupella S, Kvist M, Happel M, Korkalainen P, Chandrasekar A, Paulus U, Bokhorst A, Wulff B, Fernandez-Sojo J, Eguizabal C, Urbano F, Vesga MA, van Kraaij M, Merz EM, van den Hurk K, Hansen MB, Slot E, Ullum H. How donor selection criteria can be evaluated with limited scientific evidence: lessons learned from the TRANSPOSE project. Vox Sang 2021;116:342-50. [PMID: 33191514 DOI: 10.1111/vox.13028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Olotu AA, Oyelese AO, Salawu L, Audu RA, Okwuraiwe AP, Aboderin AO. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation. Virol J 2016;13:76. [PMID: 27150469 DOI: 10.1186/s12985-016-0533-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kang JW, Seo JH, Youn KW, Seo YI, Huh K, Choi GR, Min HK, Oh DJ, Jo HJ, Kim JN. Use of supplemental anti-HBc testing of donors showing non-discriminating reactive results in multiplex nucleic acid testing. Vox Sang 2017;112:622-7. [PMID: 28891069 DOI: 10.1111/vox.12553] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
12 El Banna N, El Jisr T, Samaha H, El Chaar M. Low Prevalence of Occult Hepatitis B Infection Among Blood Donors in Beirut, Lebanon: Reconsider the Deferral Strategy of Anti-HBc Positive Blood Donors. Hepat Mon 2017;17. [DOI: 10.5812/hepatmon.14250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Vitrone M, Iossa D, Rinaldi L, Pafundi PC, Molaro R, Parrella A, Andini R, Ragone E, Maiello C, Zampino R, Durante-Mangoni E. Hepatitis B virus reactivation after heart transplant: Incidence and clinical impact. J Clin Virol 2017;96:54-9. [PMID: 28964958 DOI: 10.1016/j.jcv.2017.09.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ghoma Linguissi LS, Nkenfou CN. Epidemiology of viral hepatitis in the Republic of Congo: review. BMC Res Notes 2017;10:665. [PMID: 29197421 DOI: 10.1186/s13104-017-2951-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Lakoh S, García-Tardón N, Adekanmbi O, van der Valk M, Smith SJ, Grobusch MP. Prevalence of viral hepatitis B and C in Sierra Leone-current knowledge and knowledge gaps: a narrative review. Trans R Soc Trop Med Hyg 2021:trab054. [PMID: 33772308 DOI: 10.1093/trstmh/trab054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Fryer JF, Heath AB, Wilkinson DE, Minor PD; Collaborative Study Group. A collaborative study to establish the 3rd WHO International Standard for hepatitis B virus for nucleic acid amplification techniques. Biologicals 2017;46:57-63. [PMID: 28082100 DOI: 10.1016/j.biologicals.2016.12.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
17 Brook G, Brockmeyer N, van de Laar T, Schellberg S, Winter AJ. 2017 European guideline for the screening, prevention and initial management of hepatitis B and C infections in sexual health settings. Int J STD AIDS 2018;29:949-67. [PMID: 29716442 DOI: 10.1177/0956462418767576] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
18 Xiong W, Lu H, Ding J. Determination of Varying Group Sizes for Pooling Procedure. Comput Math Methods Med 2019;2019:4381084. [PMID: 31065292 DOI: 10.1155/2019/4381084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Pinho-Nascimento CA, Bratschi MW, Höfer R, Soares CC, Warryn L, Pečerska J, Minyem JC, Paixão ICNP, Baroni de Moraes MT, Um Boock A, Niel C, Pluschke G, Röltgen K. Transmission of Hepatitis B and D Viruses in an African Rural Community. mSystems 2018;3:e00120-18. [PMID: 30246145 DOI: 10.1128/mSystems.00120-18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Ramachandran S, Groves JA, Xia GL, Saá P, Notari EP, Drobeniuc J, Poe A, Khudyakov N, Schillie SF, Murphy TV, Kamili S, Teo CG, Dodd RY, Khudyakov YE, Stramer SL. Recent and occult hepatitis B virus infections among blood donors in the United States. Transfusion 2019;59:601-11. [PMID: 30499591 DOI: 10.1111/trf.15057] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
21 Mardian Y, Yano Y, Wasityastuti W, Ratnasari N, Liang Y, Putri WA, Triyono T, Hayashi Y. Genetic polymorphisms of HLA-DP and isolated anti-HBc are important subsets of occult hepatitis B infection in Indonesian blood donors: a case-control study. Virol J 2017;14:201. [PMID: 29061159 DOI: 10.1186/s12985-017-0865-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
22 Armas Cayarga A, Perea Hernández Y, González González YJ, Figueredo Lago JE, Valdivia Álvarez IY, Gómez Cordero I, Santos Hernández N, Vega Sánchez H, La Rosa Hernández D, Martínez Pérez EL. Performance characteristics of a fast real-time PCR assay for hepatitis B virus DNA quantification. Biologicals 2019;58:22-7. [PMID: 30718130 DOI: 10.1016/j.biologicals.2019.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Xu T, Yi ZM, Luo JM, Yu HL, Fan YH, Lu H, Zhao SM, Jiang TL. Prevalence and trends of transfusion-transmittable infections among blood donors in Southwest China. J Public Health (Oxf) 2019;41:55-61. [PMID: 29351630 DOI: 10.1093/pubmed/fdx189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Seed CR, Allain J, Lozano M, Laperche S, Gallian P, Gross S, Kwon S, Oh E, Kim J, Chua SS, Lam S, Ang AL, Tsoi W, Hewitt PE, Davison KL, Tettmar K, O'flaherty N, Boland F, Williams P, Pomeroy L, Wendel S, Fachini R, Scuracchio P, Carminato P, Fearon M, O'brien SF, Delage G, Kiely P, Hoad V, Matsubayashi K, Satake M, Taira R, Stramer SL, Sauleda S, Bes M, Piron M, El Ekiaby M, Vermeulen M, Levičnik Stezinar S, Nograšek P, Jarvis LM, Petrik J, Charlewood R, Flanagan P, Grabarczyk P, Kopacz A, Łętowska M, Seifried E, Schmidt M. International Forum on Occult hepatitis B infection and transfusion safety. Vox Sang 2019;114:e1-e35. [DOI: 10.1111/vox.12743] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Hernández-Romano P, Hernández-Romano J, Torres-Hernández RM, González-Jiménez B, López-Balderas N. Occult hepatitis B infections and anti-HBc prevalence at a resource-limited blood bank in Mexico. Transfus Med 2020;30:396-400. [PMID: 32250006 DOI: 10.1111/tme.12681] [Reference Citation Analysis]
26 Atilola G, Tomisin O, Randle M, Isaac KO, Odutolu G, Olomu J, Adenuga L. Epidemiology of HBV in Pregnant Women, South West Nigeria. J Epidemiol Glob Health 2018;8:115-23. [PMID: 30864752 DOI: 10.2991/j.jegh.2018.09.002] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Sánchez Ibáñez J, Vilarrodona Serrat A, Seoane Pillado T, Rodriguez Aierbe C, Villalba Montoro R, Calvo Benito J, Pevida Lopez M, Fernández Paneque S, Vuelta Lopez E, Martínez Lorenzo MJ, González Romero M, Cañizares Castellanos A, Sauleda Oliveras S. Evaluation of occult hepatitis B infection in tissue donors: a multicenter analysis in Spain. Cell Tissue Bank 2019;20:513-26. [PMID: 31451994 DOI: 10.1007/s10561-019-09784-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Mikkelsen C, Mori G, van Walraven SM, Castrén J, Zahra S, MacLennan S, Seidel K, Fontana S, Veropalumbo E, Cannata L, Pupella S, Kvist M, Happel M, Korkalainen P, Wulff B, Fernandez-Sojo J, Eguizabal C, Urbano F, Vesga MA, Pozenel P, van Kraaij M, Hansen MB, Slot E, Ullum H. Putting the spotlight on donation-related risks and donor safety - are we succeeding in protecting donors? Vox Sang 2021;116:313-23. [PMID: 33103801 DOI: 10.1111/vox.13014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Drew VJ, Barro L, Seghatchian J, Burnouf T. Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prospects for developing countries. Blood Transfus 2017;15:512-21. [PMID: 28488960 DOI: 10.2450/2017.0344-16] [Cited by in F6Publishing: 10] [Reference Citation Analysis]